- Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
- Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
- Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
Key statistics
As of last trade Longboard Pharmaceuticals Inc (LBPH:NMQ) traded at 17.76, -36.92% below its 52-week high of 28.15, set on Jan 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.50 |
---|---|
High | 17.76 |
Low | 17.49 |
Bid | 17.60 |
Offer | 17.79 |
Previous close | 17.74 |
Average volume | 286.50k |
---|---|
Shares outstanding | 38.88m |
Free float | 33.24m |
P/E (TTM) | -- |
Market cap | 733.67m USD |
EPS (TTM) | -2.25 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 14:45 BST.
More ▼